{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:07:34Z","timestamp":1793826454694,"version":"4.6.1"},"reference-count":63,"publisher":"Rockefeller University Press","issue":"11","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/V016741\/1"],"award-info":[{"award-number":["BB\/V016741\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","award":["SBR005\\1104"],"award-info":[{"award-number":["SBR005\\1104"]}],"id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004350","name":"Studienstiftung des deutschen Volkes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["EXC2151-390873048"],"award-info":[{"award-number":["EXC2151-390873048"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["GE 976\/16-1"],"award-info":[{"award-number":["GE 976\/16-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["493665037"],"award-info":[{"award-number":["493665037"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002345","name":"University of T\u00fcbingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002345","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Baden-W\u00fcrttemberg Federal Ministry of Science, Research and Arts"},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-22-CE15-0032-01"],"award-info":[{"award-number":["ANR-22-CE15-0032-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Republic of Kazakhstan"},{"DOI":"10.13039\/501100000873","name":"Queen\u2019s University Belfast","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,3]]},"abstract":"<jats:p>The NLRP3 inflammasome is an intracellular protein complex that causes inflammation via the release of IL-1\u03b2 and pyroptosis. NLRP3 activation is associated with many age-related inflammatory diseases, and NLRP3 inhibition is a promising therapeutic strategy. We previously performed a DNA-encoded library screen to identify novel NLRP3-binding molecules. Herein we describe the characterization of BAL-0028 as a potent and specific inhibitor of NLRP3 signaling. Notably, BAL-0028 is a poor inhibitor of mouse NLRP3 but inhibits human and primate NLRP3 with nanomolar potency. Using cellular and biochemical analyses, we demonstrate that BAL-0028 binds to the NLRP3 NACHT domain at a site that is distinct from the MCC950-binding pocket. Using humanized NLRP3 mice, we show that a derivative of BAL-0028, BAL-0598, inhibits NLRP3 activation in vivo in a peritonitis model. Finally, we demonstrate that both BAL-0028 and BAL-0598 inhibit select hyperactive NLRP3 mutations associated with autoinflammatory diseases more potently than MCC950. BAL-0028 and BAL-0598 thus represent a new modality for NLRP3 inhibition in inflammatory diseases.<\/jats:p>","DOI":"10.1084\/jem.20242403","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T06:20:47Z","timestamp":1753338047000},"update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":23,"title":["Discovery of potent and selective inhibitors of human NLRP3 with a novel mechanism of action"],"prefix":"10.1084","volume":"222","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6518-6369","authenticated-orcid":true,"given":"Kevin","family":"Wilhelmsen","sequence":"first","affiliation":[{"name":"BioAge Labs 1 , Emeryville, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5184-5658","authenticated-orcid":true,"given":"Aditi","family":"Deshpande","sequence":"additional","affiliation":[{"name":"BioAge Labs 1 , Emeryville, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5357-046X","authenticated-orcid":true,"given":"Sarah","family":"Tronnes","sequence":"additional","affiliation":[{"name":"BioAge Labs 1 , Emeryville, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8920-4159","authenticated-orcid":true,"given":"Maitriyee","family":"Mahanta","sequence":"additional","affiliation":[{"name":"BioAge Labs 1 , Emeryville, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7539-1012","authenticated-orcid":true,"given":"Matthew","family":"Banicki","sequence":"additional","affiliation":[{"name":"BioAge Labs 1 , Emeryville, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6277-6536","authenticated-orcid":true,"given":"Mary","family":"Cochran","sequence":"additional","affiliation":[{"name":"BioAge Labs 1 , Emeryville, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6067-306X","authenticated-orcid":true,"given":"Samantha","family":"Cowdin","sequence":"additional","affiliation":[{"name":"BioAge Labs 1 , Emeryville, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5844-5399","authenticated-orcid":true,"given":"Kristen","family":"Fortney","sequence":"additional","affiliation":[{"name":"BioAge Labs 1 , Emeryville, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8016-8369","authenticated-orcid":true,"given":"George","family":"Hartman","sequence":"additional","affiliation":[{"name":"BioAge Labs 1 , Emeryville, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5650-2802","authenticated-orcid":true,"given":"Robert E.","family":"Hughes","sequence":"additional","affiliation":[{"name":"BioAge Labs 1 , Emeryville, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7193-2468","authenticated-orcid":true,"given":"Rusty","family":"Montgomery","sequence":"additional","affiliation":[{"name":"BioAge Labs 1 , Emeryville, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6436-3931","authenticated-orcid":true,"given":"Claudia P.","family":"Portillo","sequence":"additional","affiliation":[{"name":"BioAge Labs 1 , Emeryville, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7095-4944","authenticated-orcid":true,"given":"Paul","family":"Rubin","sequence":"additional","affiliation":[{"name":"BioAge Labs 1 , Emeryville, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5063-1788","authenticated-orcid":true,"given":"Taiz","family":"Salazar","sequence":"additional","affiliation":[{"name":"BioAge Labs 1 , Emeryville, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3639-8585","authenticated-orcid":true,"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"BioAge Labs 1 , Emeryville, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5046-8427","authenticated-orcid":true,"given":"Shijun","family":"Yan","sequence":"additional","affiliation":[{"name":"BioAge Labs 1 , Emeryville, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6821-5129","authenticated-orcid":true,"given":"Barry A.","family":"Morgan","sequence":"additional","affiliation":[{"name":"HitGen Pharmaceuticals Inc. 2 , Houston, TX,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9997-1517","authenticated-orcid":true,"given":"Assem","family":"Duisembekova","sequence":"additional","affiliation":[{"name":"CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon 3 , Lyon,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2345-8503","authenticated-orcid":true,"given":"Romane","family":"Riou","sequence":"additional","affiliation":[{"name":"CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon 3 , Lyon,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1994-8227","authenticated-orcid":true,"given":"Michael","family":"Marleaux","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/041nas322","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Structural Biology, University of Bonn 4 , Bonn,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6649-2624","authenticated-orcid":true,"given":"Inga V.","family":"Hochheiser","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/041nas322","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Structural Biology, University of Bonn 4 , Bonn,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8231-1791","authenticated-orcid":true,"given":"Hannes","family":"Buthmann","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/041nas322","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Structural Biology, University of Bonn 4 , Bonn,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2633-2858","authenticated-orcid":true,"given":"Dominic","family":"Ferber","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/041nas322","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Structural Biology, University of Bonn 4 , Bonn,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3257-8483","authenticated-orcid":true,"given":"Jane","family":"Torp","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/041nas322","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Structural Biology, University of Bonn 4 , Bonn,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8156-9754","authenticated-orcid":true,"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00hswnk62","id-type":"ROR","asserted-by":"publisher"}],"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast 5 , Belfast,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9068-2593","authenticated-orcid":true,"given":"Melanie","family":"Cranston","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00hswnk62","id-type":"ROR","asserted-by":"publisher"}],"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast 5 , Belfast,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2882-165X","authenticated-orcid":true,"given":"Chloe M.","family":"McKee","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00hswnk62","id-type":"ROR","asserted-by":"publisher"}],"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast 5 , Belfast,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8657-2455","authenticated-orcid":true,"given":"Thea J.","family":"Mawhinney","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00hswnk62","id-type":"ROR","asserted-by":"publisher"}],"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast 5 , Belfast,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6632-2010","authenticated-orcid":true,"given":"Emma C.","family":"McKay","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00hswnk62","id-type":"ROR","asserted-by":"publisher"}],"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast 5 , Belfast,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2364-4282","authenticated-orcid":true,"given":"Fehime K.","family":"Eroglu","sequence":"additional","affiliation":[{"name":"Institute of Immunology 6 Department of Innate Immunity, , T\u00fcbingen,","place":["Germany"]},{"name":"Pediatric Rheumatology and Autoinflammation Reference Center, University Hospital T\u00fcbingen 7 Department of Pediatrics I, , T\u00fcbingen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6365-6598","authenticated-orcid":true,"given":"Jasmin","family":"K\u00fcmmerle-Deschner","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology and Autoinflammation Reference Center, University Hospital T\u00fcbingen 7 Department of Pediatrics I, , T\u00fcbingen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8627-7056","authenticated-orcid":true,"given":"Alexander N.R.","family":"Weber","sequence":"additional","affiliation":[{"name":"Institute of Immunology 6 Department of Innate Immunity, , T\u00fcbingen,","place":["Germany"]},{"id":[{"id":"https:\/\/ror.org\/03a1kwz48","id-type":"ROR","asserted-by":"publisher"}],"name":"Cluster of Excellence 2180 \u201cImage-guided and Functionally Instructed Tumor Therapies\u201d and Cluster of Excellence 2124 \u201cControlling Microbes to Fight Infection\u201d, University of T\u00fcbingen 8 , T\u00fcbingen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6716-7807","authenticated-orcid":true,"given":"B\u00e9n\u00e9dicte F.","family":"Py","sequence":"additional","affiliation":[{"name":"CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon 3 , Lyon,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7718-5002","authenticated-orcid":true,"given":"Matthias","family":"Geyer","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/041nas322","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Structural Biology, University of Bonn 4 , Bonn,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7359-6023","authenticated-orcid":true,"given":"Rebecca C.","family":"Coll","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00hswnk62","id-type":"ROR","asserted-by":"publisher"}],"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast 5 , Belfast,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"2025090209544173300_bib1","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s41423-022-00922-w","article-title":"How location and cellular signaling combine to activate the NLRP3 inflammasome","volume":"19","author":"Akbal","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"2025090209544173300_bib2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gene.2004.05.002","article-title":"Structural, expression, and evolutionary analysis of mouse CIAS1","volume":"338","author":"Anderson","year":"2004","journal-title":"Gene"},{"key":"2025090209544173300_bib3","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.cell.2023.04.025","article-title":"A 360\u00b0 view of the inflammasome: Mechanisms of activation, cell death, and diseases","volume":"186","author":"Barnett","year":"2023","journal-title":"Cell"},{"key":"2025090209544173300_bib4","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/s42003-023-05684-3","article-title":"NLRP1- A CINDERELLA STORY: A perspective of recent advances in NLRP1 and the questions they raise","volume":"6","author":"Barry","year":"2023","journal-title":"Commun. Biol."},{"key":"2025090209544173300_bib5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1084\/jem.20172222","article-title":"Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity","volume":"215","author":"Boucher","year":"2018","journal-title":"J. Exp. Med."},{"key":"2025090209544173300_bib6","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/s42003-022-04120-2","article-title":"ATP-binding and hydrolysis of human NLRP3","volume":"5","author":"Brinkschulte","year":"2022","journal-title":"Commun. Biol."},{"key":"2025090209544173300_bib7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: Mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"2025090209544173300_bib8","doi-asserted-by":"publisher","first-page":"1190219","DOI":"10.3389\/fimmu.2023.1190219","article-title":"Divergent functional outcomes of NLRP3 blockade downstream of multi-inflammasome activation: Therapeutic implications for ALS","volume":"14","author":"Cl\u00e9net","year":"2023","journal-title":"Front. Immunol."},{"key":"2025090209544173300_bib9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/B978-0-323-91802-2.00010-4","article-title":"Therapeutic targeting of inflammasome signaling by blocking interleukin-1","volume-title":"Inflammasome Biology","author":"Coll","year":"2023"},{"key":"2025090209544173300_bib10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"2025090209544173300_bib11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"2025090209544173300_bib12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","article-title":"NLRP3 and pyroptosis blockers for treating inflammatory diseases","volume":"43","author":"Coll","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"2025090209544173300_bib13","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1124\/pharmrev.120.000171","article-title":"Pharmacological inhibition of the nod-like receptor family pyrin domain containing 3 inflammasome with MCC950","volume":"73","author":"Corcoran","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"2025090209544173300_bib14","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231200","article-title":"Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammation","volume":"221","author":"Cosson","year":"2024","journal-title":"J. Exp. Med."},{"key":"2025090209544173300_bib15","doi-asserted-by":"publisher","first-page":"12504","DOI":"10.1038\/ncomms12504","article-title":"Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models","volume":"7","author":"Daniels","year":"2016","journal-title":"Nat. Commun."},{"key":"2025090209544173300_bib16","doi-asserted-by":"publisher","first-page":"167309","DOI":"10.1016\/j.jmb.2021.167309","article-title":"Crystal structure of NLRP3 NACHT domain with an inhibitor defines mechanism of inflammasome inhibition","volume":"433","author":"Dekker","year":"2021","journal-title":"J. Mol. Biol."},{"key":"2025090209544173300_bib17","doi-asserted-by":"publisher","first-page":"6901","DOI":"10.3390\/ijms21186901","article-title":"An update on CARD only proteins (COPs) and PYD only proteins (POPs) as inflammasome regulators","volume":"21","author":"Devi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"2025090209544173300_bib18","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.4361","article-title":"Differentiation of human induced pluripotent stem cell into macrophages","volume":"12","author":"Douthwaite","year":"2022","journal-title":"Bio. Protoc."},{"key":"2025090209544173300_bib19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nature07710","article-title":"AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA","volume":"458","author":"Fernandes-Alnemri","year":"2009","journal-title":"Nature"},{"key":"2025090209544173300_bib20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.mad.2016.09.009","article-title":"Interventions for age-related diseases: Shifting the paradigm","volume":"160","author":"Figueira","year":"2016","journal-title":"Mech. Ageing Dev."},{"key":"2025090209544173300_bib21","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: A new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"2025090209544173300_bib22","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41577-024-00995-w","article-title":"Mechanistic insights from inflammasome structures","volume":"24","author":"Fu","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"2025090209544173300_bib23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.clim.2017.11.011","article-title":"An optimized whole blood assay measuring expression and activity of NLRP3, NLRC4 and AIM2 inflammasomes","volume":"191","author":"Grinstein","year":"2018","journal-title":"Clin. Immunol."},{"key":"2025090209544173300_bib63","volume-title":"Inhibitors of NLRP3 Inflammasome","author":"Hartman","year":"2023"},{"key":"2025090209544173300_bib64","volume-title":"Inhibitors of NLRP3 Inflammasome","author":"Hartman","year":"2023"},{"key":"2025090209544173300_bib25","doi-asserted-by":"publisher","first-page":"129675","DOI":"10.1016\/j.bmcl.2024.129675","article-title":"The discovery of novel and potent indazole NLRP3 inhibitors enabled by DNA-encoded library screening","volume":"102","author":"Hartman","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2025090209544173300_bib26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn7583","article-title":"Directionality of PYD filament growth determined by the transition of NLRP3 nucleation seeds to ASC elongation","volume":"8","author":"Hochheiser","year":"2022","journal-title":"Sci. Adv."},{"key":"2025090209544173300_bib27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41586-022-04467-w","article-title":"Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3","volume":"604","author":"Hochheiser","year":"2022","journal-title":"Nature"},{"key":"2025090209544173300_bib28","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC","volume":"458","author":"Hornung","year":"2009","journal-title":"Nature"},{"key":"2025090209544173300_bib29","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"2025090209544173300_bib30","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J. Exp. Med."},{"key":"2025090209544173300_bib31","doi-asserted-by":"publisher","first-page":"114194","DOI":"10.1016\/j.ejmech.2022.114194","article-title":"Discovery of a novel and potent inhibitor with differential species-specific effects against NLRP3 and AIM2 inflammasome-dependent pyroptosis","volume":"232","author":"Jiao","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"2025090209544173300_bib32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.arr.2015.02.005","article-title":"Innate immune perturbations, accumulating DAMPs and inflammasome dysregulation: A ticking time bomb in ageing","volume":"24","author":"Kapetanovic","year":"2015","journal-title":"Ageing Res. Rev."},{"key":"2025090209544173300_bib33","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1021\/acschembio.1c00218","article-title":"A probe for NLRP3 inflammasome inhibitor MCC950 identifies carbonic anhydrase 2 as a novel target","volume":"16","author":"Kennedy","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"2025090209544173300_bib34","doi-asserted-by":"publisher","first-page":"113852","DOI":"10.1016\/j.celrep.2024.113852","article-title":"Species-specific NLRP3 regulation and its role in CNS autoinflammatory diseases","volume":"43","author":"Koller","year":"2024","journal-title":"Cell Rep."},{"key":"2025090209544173300_bib35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-1-62703-444-9_10","article-title":"DNA transfection: Calcium phosphate method","volume":"1018","author":"Kwon","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"2025090209544173300_bib36","doi-asserted-by":"publisher","first-page":"16567","DOI":"10.1074\/jbc.M211596200","article-title":"Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing","volume":"278","author":"Laliberte","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2025090209544173300_bib37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1083\/jcb.200903124","article-title":"Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome","volume":"187","author":"Lamkanfi","year":"2009","journal-title":"J. Cell Biol."},{"key":"2025090209544173300_bib38","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"2025090209544173300_bib39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41594-023-01143-z","article-title":"Structural basis of the human NAIP\/NLRC4 inflammasome assembly and pathogen sensing","volume":"31","author":"Matico","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2025090209544173300_bib40","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/JLB.3MR0720-513R","article-title":"NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma","volume":"108","author":"McKee","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"2025090209544173300_bib41","doi-asserted-by":"publisher","first-page":"107386","DOI":"10.1016\/j.jbc.2024.107386","article-title":"Post-translational control of NLRP3 inflammasome signaling","volume":"300","author":"O\u2019Keefe","year":"2024","journal-title":"J. Biol. Chem."},{"key":"2025090209544173300_bib42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2121353119","article-title":"Structural basis for the oligomerization-mediated regulation of NLRP3 inflammasome activation","volume":"119","author":"Ohto","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025090209544173300_bib43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-1-4939-2269-7_22","article-title":"Drug affinity responsive target stability (DARTS) for small-molecule target identification","volume":"1263","author":"Pai","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"2025090209544173300_bib44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1189\/jlb.1006627","article-title":"MDP-induced interleukin-1beta processing requires Nod2 and CIAS1\/NALP3","volume":"82","author":"Pan","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"2025090209544173300_bib45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3565(24)29317-4","article-title":"Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors","volume":"299","author":"Perregaux","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2025090209544173300_bib46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/imr.13292","article-title":"The discovery of NLRP3 and its function in cryopyrin-associated periodic syndromes and innate immunity","volume":"322","author":"Putnam","year":"2023","journal-title":"Immunol. Rev."},{"key":"2025090209544173300_bib47","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"2025090209544173300_bib48","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1016\/j.celrep.2017.12.018","article-title":"The inflammasome drives GSDMD-independent secondary pyroptosis and IL-1 release in the absence of caspase-1 protease activity","volume":"21","author":"Schneider","year":"2017","journal-title":"Cell Rep."},{"key":"2025090209544173300_bib49","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4049\/jimmunol.1401110","article-title":"A novel flow cytometric method to assess inflammasome formation","volume":"194","author":"Sester","year":"2015","journal-title":"J. Immunol."},{"key":"2025090209544173300_bib50","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1124\/jpet.123.001941","article-title":"Target cell activation of a structurally novel NOD-like receptor pyrin domain-containing protein 3 inhibitor NT-0796 enhances potency","volume":"388","author":"Smolak","year":"2024","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2025090209544173300_bib51","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1016\/j.celrep.2016.11.052","article-title":"An NLRP3 mutation causes arthropathy and osteoporosis in humanized mice","volume":"17","author":"Snouwaert","year":"2016","journal-title":"Cell Rep."},{"key":"2025090209544173300_bib52","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: Molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"2025090209544173300_bib53","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41589-019-0278-6","article-title":"MCC950 closes the active conformation of NLRP3 to an inactive state","volume":"15","author":"Tapia-Abell\u00e1n","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"2025090209544173300_bib54","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.chembiol.2023.09.016","article-title":"Interrogating direct NLRP3 engagement and functional inflammasome inhibition using cellular assays","volume":"31","author":"Teske","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"2025090209544173300_bib55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","article-title":"Drugging the NLRP3 inflammasome: From signalling mechanisms to therapeutic targets","volume":"23","author":"Vande Walle","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"2025090209544173300_bib56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000354","article-title":"MCC950\/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition","volume":"17","author":"Vande Walle","year":"2019","journal-title":"PLoS Biol."},{"key":"2025090209544173300_bib57","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202402644","article-title":"Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with high potency","volume":"7","author":"Vande Walle","year":"2024","journal-title":"Life Sci. Alliance"},{"key":"2025090209544173300_bib58","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1124\/jpet.106.111344","article-title":"(S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoy l)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme\/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18","volume":"321","author":"Wannamaker","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2025090209544173300_bib59","doi-asserted-by":"publisher","first-page":"13152","DOI":"10.1021\/acs.jmedchem.1c00910","article-title":"Strategies for structural modification of small molecules to improve blood-brain barrier penetration: A recent perspective","volume":"64","author":"Xiong","year":"2021","journal-title":"J. Med. Chem."},{"key":"2025090209544173300_bib60","doi-asserted-by":"publisher","first-page":"14408","DOI":"10.1073\/pnas.1306376110","article-title":"Human NAIP and mouse NAIP1 recognize bacterial type III secretion needle protein for inflammasome activation","volume":"110","author":"Yang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025090209544173300_bib61","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/s41467-024-45396-8","article-title":"Structural basis for the oligomerization-facilitated NLRP3 activation","volume":"15","author":"Yu","year":"2024","journal-title":"Nat. Commun."},{"key":"2025090209544173300_bib62","doi-asserted-by":"publisher","first-page":"18864","DOI":"10.1074\/jbc.RA118.004350","article-title":"Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding","volume":"293","author":"Zhong","year":"2018","journal-title":"J. Biol. Chem."}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20242403\/1949711\/jem_20242403.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20242403\/1949711\/jem_20242403.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T13:54:52Z","timestamp":1756821292000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/222\/11\/e20242403\/278297\/Discovery-of-potent-and-selective-inhibitors-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":63,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,3]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20242403","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"article-number":"e20242403"}}